Evaluation and Comparison of Urolithiasis Scoring Systems Used in Percutaneous Kidney Stone Surgery

Evaluation and Comparison of Urolithiasis Scoring Systems Used in Percutaneous Kidney Stone Surgery

Author's Accepted Manuscript Evaluation and Comparison of Urolithiaisis Scoring Systems in Percutaneous Kidney Stone Surgery Kevin Labadie, Zhamshid O...

187KB Sizes 62 Downloads 166 Views

Author's Accepted Manuscript Evaluation and Comparison of Urolithiaisis Scoring Systems in Percutaneous Kidney Stone Surgery Kevin Labadie, Zhamshid Okhunov, Arash Akhavein, Daniel Moreira, Jorge Moreno-Palacios, Michael del Junco, Zeph Okeke, Vincent Bird, Arthur D. Smith, Jaime Landman PII: DOI: Reference:

S0022-5347(14)04142-1 10.1016/j.juro.2014.07.104 JURO 11679

To appear in: The Journal of Urology Accepted Date: 22 July 2014 Please cite this article as: Labadie K, Okhunov Z, Akhavein A, Moreira D, Moreno-Palacios J, del Junco M, Okeke Z, Bird V, Smith AD, Landman J, Evaluation and Comparison of Urolithiaisis Scoring Systems in Percutaneous Kidney Stone Surgery, The Journal of Urology® (2014), doi: 10.1016/ j.juro.2014.07.104. DISCLAIMER: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our subscribers we are providing this early version of the article. The paper will be copy edited and typeset, and proof will be reviewed before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to The Journal pertain. All press releases and the articles they feature are under strict embargo until uncorrected proof of the article becomes available online. We will provide journalists and editors with full-text copies of the articles in question prior to the embargo date so that stories can be adequately researched and written. The standard embargo time is 12:01 AM ET on that date.

ACCEPTED MANUSCRIPT

RI PT

EVALUATION AND COMPARISON OF UROLITHIAISIS SCORING SYSTEMS IN PERCUTANEOUS KIDNEY STONE SURGERY

Kevin Labadie1*, Zhamshid Okhunov1*, Arash Akhavein2, Daniel Moreira3, Jorge Moreno-Palacios1, Michael del Junco1, Zeph Okeke3, Vincent Bird2, Arthur D. Smith3 and Jaime Landman1

M AN U

SC

1. Department of Urology, University of California, Irvine 2. Department of Urology, University of Florida, Gainesville 3. Smith Institute for Urology, North Shore LIJ Health System

Corresponding Author:

TE D

*Co-first authors

AC C

EP

Jaime Landman, MD Professor of Urology and Radiology, Chairman, Department of Urology University of California, Irvine Email: [email protected] Tel: 714-456-3330 333 City Boulevard West, Suite 2100 Orange, CA 92868

Keywords: percutaneous nephrolithotomy, urolithiasis, scoring system, nomograms Abbreviations: percutaneous nephrolithotomy (PCNL), computerized tomography (CT), stone free status (SFS)

ACCEPTED MANUSCRIPT Abstract Introduction: Contemporary predictive tools for PCNL outcomes include Guy’s Stone Score, S.T.O.N.E. Nephrolithometry, and CROES (Clinical Research Office of the Endourological Society) nephrolithometric nomogram. We compared each scoring

RI PT

system using the same cohort to determine which was the most predictive of surgical outcomes.

Methods: We retrospectively reviewed patients who underwent PCNL between 2009 and 2012 at three academic institutions. We calculated Guy’s Stone Score, S.T.O.N.E.

SC

Nephrolithometry, and CROES nephrolithometric nomogram based on preoperative computerized tomography (CT) images. A single observer at each institution reviewed

M AN U

all images and assigned scores. Univariate and multivariate analysis was performed to determine the most predictive scoring system.

Results: We enrolled 246 patients. Mean Guy’s Scores for patients who were stonefree versus who had residual stones were 2.2 and 2.7 respectively (p<0.001). Mean S.T.O.N.E. scores for patients who were stone-free versus who had residual stones were 8.3 and 9.5, respectively (p<0.001). Mean CROES nomogram scores for patients

TE D

who were stone free versus those who had residual stones were 222 and 187, respectively (p<0.001). In logistic regression analysis, Guy’s Score, S.T.O.N.E. Nephrolithometry and CROES nomogram were significantly associated with stone-free status (SFS), (p= 0.02, 0.004, <0.001 respectively). Guy’s Score and S.T.O.N.E.

EP

Nephrolithometry were associated with estimated blood loss (EBL) (p<0.0001, p=0.03) and length of stay (LOS) (p=0.03, p=0.009 respectively). The CROES nomogram was

AC C

not predictive of EBL or LOS.

Conclusions: All scoring systems and stone burden were equally predictive of SFS. Guy’s Score and S.T.O.N.E. Nephrolithometry were associated with EBL and LOS. A single scoring system should be adopted to unify reporting.

ACCEPTED MANUSCRIPT INTRODUCTION There has been a marked increase in the prevalence of kidney stone disease in the United States within the last two decades approaching 7% in females and 10.3% in

RI PT

males in 20101. With this dramatic increase in incidence and prevalence of stone disease, the use of percutaneous nephrolithotomy (PCNL) for the treatment of large burden stones has continued to rise2-4. Despite continuous refinements in surgical

SC

techniques and technology, the overall complication rates for PCNL have increased5. An accurate estimate of treatment success is crucial for optimal decision-making and

M AN U

informed patient counseling. To characterize the complexity of kidney stones, preoperative radiologic evaluation with computerized tomography (CT) has become common practice in the United States. CT scans provide high resolution spatial imaging for accurate characterization of stone size and distribution, pelvicaliceal anatomy, anomalies and anatomical relationships which may dictate the feasibility and risks of

TE D

different treatment modalities. With these measurable stone and patient features, the Guy’s Stone Score6, S.T.O.N.E. Nephrolithometry7, and CROES nephrolithometric been introduced for systematic and quantitative assessment of

EP

nomogram8 have

kidney stones. In addition to imaging characteristics, these models also take into

AC C

account other patient features that contribute to disease outcome such as obesity, prior renal surgical history, spinal cord injury and spina bifida status, as well as surgeon experience. These different parameters are thought to provide the surgeon with an assessment of the complexity and intricacies of each individual patient. These scoring systems serve as disease stratification tools that allow the surgeon to more accurately predict outcomes of PCNL in order to improve patient counseling and surgical planning68

.

ACCEPTED MANUSCRIPT Another potential advantage of scoring systems is the uniform and standardized reporting across the different series. To date, comparative evaluation of treatment for urolithiasis has been limited by the lack of a widely accepted standardization system 9,10

RI PT

. Uniform academic and clinical reporting empowers physicians to better compare

data from different institutions, and will improve overall quality of urologic research. To date, there has been no direct comparison of existing scoring systems

6-8

.

SC

Comparison and analyses of these tools support refinements and improvements in these systems that may ultimately facilitate creation of a more universal and widely

M AN U

accepted scoring system. As such, we evaluated and compared these scoring systems in order to assess their relative predictive value for surgical outcomes. Additionally, we review features of each of these systems, their similarities and differences, their

AC C

EP

TE D

applicability in clinical practice and relevance in academic reporting

ACCEPTED MANUSCRIPT METHODS After obtaining Institutional Board Review approval, we performed a retrospective chart review on patients who underwent PCNL between 2009 and 2012 at three

RI PT

academic institutions. Selection criteria

Exclusion criteria included patients younger than 18 years old, a history of prior

SC

surgery on the ipsilateral kidney, nephrostomy tube or stent placement in the ipsilateral kidney prior to surgery, and patients with no available preoperative CT images. Patients

M AN U

who underwent repeat PCNL for recurrent stones on the ipsilateral kidney were included in the analysis. If a patient had bilateral procedures we selected one side at random to improve the independence of the data points.

TE D

Measurements

We calculated the Guy’s Score, S.T.O.N.E. Nephrolithometry, and CROES nephrolithometric nomogram on all patients based on preoperative CT images as 6 7 8

. A single observer from

EP

described by Thomas, Okhunov and Smith respectively

each institution reviewed all images and performed scoring according to each system.

AC C

We provided standardized instructions to all reviewers on the application of each scoring system prior to data collection. Perioperative Data

We collected patient demographic, clinical, perioperative and follow-up data in a retrospective fashion. The information collected included age, gender, body mass index (BMI), previous surgical history, medical history, presence of renal anomalies, American Society of Anesthesiologists Score (ASA), estimated blood loss (EBL), fluoroscopy time

ACCEPTED MANUSCRIPT (FT), operative time (OT), stone location and size, number of renal punctures, number and location of tracts dilated, and intraoperative and postoperative complications within 30 days and length of stay (LOS).

RI PT

Outcomes

The primary outcome of our study was to compare the ability of the Guy’s Score, S.T.O.N.E. Nephrolithometry and CROES nomogram to predict stone free rates

SC

following PCNL. We defined stone free rate status in our study as absence of residual stones or stone fragments <2mm at the termination of the procedure as confirmed by 11,12

M AN U

. CT scans were obtained on all patients prior to

postoperative CT imaging

discharge or within the 3 months of the surgery.

The secondary outcome was to evaluate the ability of the scoring systems to predict perioperative and postoperative complications within 30 days of the procedure.

modified Clavien system

Our

. Additionally, we evaluated perioperative variables such as

EP

FT, OT, EBL, and LOS.

13

TE D

We classified all intraoperative and postoperative complications according to the

surgical

techniques

have

been

described

previously14,15.

All

AC C

participating institutions have substantial experience with the PCNL procedure and the surgical technique is performed in a similar fashion between the three academic institutions. Statistical analysis

We divided patients in two groups based upon postoperative SFS (SFS). Comparisons of baseline characteristics between stone free and non-stone free subjects were performed using chi-square test for categorical variables and Student t

ACCEPTED MANUSCRIPT test for continuous data. Guy’s Score and CROES nomogram were divided in 4 groups and S.T.O.N.E. Nephrolithometry in 3. Descriptive statistics were used to show the stone free rate across the 4-category groups for each scoring system. Receiver

RI PT

operator characteristic (ROC) curves were generated for each scoring system and for stone burden (measured in mm2). Area under the curve and asymptotic 95% confidence intervals were calculated for each ROC curve. All statistical analyses were two-tailed

SC

and performed using Stata 12.0 (StataCorp, College Station, TX) and R 3.0.1 (R Foundation for Statistical Computing, Vienna, Austria). A p value of <0.05 was

AC C

EP

TE D

M AN U

considered statistically significant.

ACCEPTED MANUSCRIPT RESULTS: We identified a total of 246 patients who underwent a PCNL between 2009 and 2012 who met the inclusion criteria. Patient demographics and stone characteristics are

RI PT

demonstrated in Table 1. Perioperative Data

The overall single procedure stone free rate in the study was 56%. The mean

respectively

(p<0.001).

Overall,

42

(17%)

patients

experienced

M AN U

1525mm2,

SC

stone size in stone free patients and patients with residual stones was 654mm2 and

postoperative complications including 23 Clavien grade I (fever, pain management with NSAIDS), 8 Clavien grade II (fever treated with antibiotics, AKI managed with IV fluids), 5 Clavien grade IIIA (obstruction requiring nephrostomy tube placement, double JJ stent causing infundibular rupture), 3 Clavien grade IIIB (significant bleeding requiring

TE D

angioembolization, bleeding requiring nephrectomy, renal abscess treated with nephrectomy in the postoperative period) and 3 Clavien grade IVA (AKI hemodialysis,

Scoring Systems

EP

septic shock). There were no mortalities.

AC C

The mean Guy’s Score for patients who were stone free or had residual stones was 2.2 and 2.7 respectively (p<0.001). The mean S.T.O.N.E. Nephrolithometry scores for patients who were stone free or had residual stones was 8.3 and 9.5 respectively (p<0.001). The mean CROES nomogram score for patients who were stone free or had residual stones was 222 and 187 respectively (p<0.001). The stone free percentages for each

scoring

system

are

illustrated

in

Table

2.

Guy’s

Score,

S.T.O.N.E.

ACCEPTED MANUSCRIPT Nephrolithometry and the CROES nomogram divided in groups were significantly associated with SFS (P = 0.002, 0.004 and <0.001 respectively). Table 3 and Figure 1 show the AUC and ROC curves for each of the scoring

RI PT

systems and stone burden alone. All scoring systems demonstrated similar accuracy. None of the scoring systems were more predictive of SFS than stone burden alone. The Guy’s Score and S.T.O.N.E Nephrolithometry were significantly associated with EBL

SC

and LOS (p <0.0001, p=0.03 and p=0.03, p=0.009 respectively), whereas CROES nomogram was not found to be significantly associated with neither complications, EBL

AC C

EP

TE D

M AN U

or LOS.

ACCEPTED MANUSCRIPT DISCUSSION: Prediction and decision-aiding tools are different in their design and methodology. Nomograms, risk groupings, probability tables and classification and

RI PT

regression tree analyses are the few most commonly applied examples. Although the three scoring systems evaluated in this study are different in their development concept, they all are aimed at predicting stone free rates and complications while serving as disease stratification tools that provide both the surgeon and the patient with information

SC

on the individual procedure complexity6-8.

M AN U

Cumulatively, the Guy’s Score, S.T.O.N.E. Nephrolithometry and CROES nomogram incorporate a total of 11 variables. Of these, only four are shared: stone location, staghorn status, stone size and number. The seven other variables (tract length, renal pelvic obstruction, stone density, case volume/year, number of stones, prior treatment history, renal anatomy and presence of spina bifida or spinal injury) are

TE D

included separately in each scoring system. Additional key differences are the method by which each accounts for anatomical features of the patient. The Guy’s Score includes

abnormal

renal

anatomy

and

calyceal

diverticulum.

S.T.O.N.E.

EP

Nephrolithometry and CROES nomogram do not take into account renal anomalies, but

AC C

S.T.O.N.E. Nephrolithometry does account for other anatomical features mentioned above. However, results from large-scale studies demonstrated that abnormal renal anatomy is not associated with inferior surgical outcomes16,17. In this study, we compared the three scoring systems in a single cohort of patients that underwent PCNL. Although the heterogeneity of the scoring systems make analysis and direct comparison complex, they can be generally compared using a single

ACCEPTED MANUSCRIPT patient cohort via reliable statistical methods. To our best knowledge, our study provides the first comparison of the three scoring systems in the same patient cohort. We

demonstrated

equal

capacities

of

the

Guy’s

Score,

S.T.O.N.E.

RI PT

Nephrolithometry, and CROES nephrolithometric nomogram in predicting SFS. In the current series none of the scoring systems were more predictive of SFS than stone burden alone.

This finding is contradictory to the initial series presented for these 6,7

. This discrepancy may be a function of the fact that each

SC

classification systems

system was constructed based on the population of patients tested. This introduces an

M AN U

intrinsic biased favoring predictive efficacy. Consistent with all previous reports, stone size undoubtedly remains the leading predictor of perioperative outcomes. In addition to the primary outcome, the Guy’s Score and S.T.O.N.E. Nephrolithometry were significantly associated with perioperative outcomes. Overall,

TE D

these scoring systems attempt to incorporate important variables in an efficient and simple manner to quantitate renal stone complexity. Given the similar predictive abilities of all three systems, it is up to urologists to decide which of these will be implemented

EP

and used in clinical practice and academic reporting.

AC C

There have been numerous studies published that have externally validated Guy’s Score and S.T.O.N.E. Nephrolithometry. External validation of the Guy’s Score was reported in two separate studies by Mandal

18

and Ingirmasson

19

demonstrating

the scoring system effectively predicted SFS. External validation of S.T.O.N.E. Nephrolithometry was conducted in a multi-institutional study with 850 patients, showing that the model was significantly associated with SFS, overall complication rate (P=0.008), EBL (P=0.001), OT (P<0.001), and LOS (P=0.016)20. Akhavein and colleagues evaluated S.T.O.N.E. Nephrolithometry including 117 patients with strict

ACCEPTED MANUSCRIPT criteria for surgical outcomes21. In this study, the stone free rate was 75% and the S.T.O.N.E. score ranged from 6 to 12. In a logistic regression model, the scoring system was significantly associated with SFS. Both the Guy’s Score and S.T.O.N.E.

RI PT

Nephrolithometry have been demonstrated to show excellent interobserver reliability 19,22

. To date, the CROES nomogram has yet to be externally validated.

Guy’s Score and S.T.O.N.E. Nephrolithometry use risk groups to determine the

SC

risk of an event. Having categories of potential risk groups allows for improved differential stratification and selection of homogeneous patients that will serve as a

M AN U

benchmark to assess the quality of various interventions in efforts to achieve superior patient care and outcomes. Although grouping homogenous patients into risk groups allows discriminating of low, medium and high-risk patients, this methodology is associated with assumption that patients within a risk group are equal. Initial report of S.T.O.N.E. Nephrolithometry demonstrated that each increase in score is associated

TE D

with 1.5 more likelihood of experiencing a complication. Indeed, patients with S.T.O.N.E. scores of 9-13, which are high-risk group patients, have different risks of

EP

having adverse events. This differs from the Guy’s Score in which there is significant overlap in the way patients are graded. For example, patients with partial or complete

AC C

staghorn are classified into grades 3 and 4 respectively. Given the poor and vague definitions of partial and complete staghorn stones, significant overlap and variations may potentially under or over grade the patient thus reducing the accuracy of the scoring system. Thomas and colleagues indeed have highlighted this in their original manuscript. Their data demonstrated a poor interobserver agreement when reviewers graded patients with partial versus complete staghorn stones6. In contrast, nomograms have been shown to be of superior performance in other areas of urological research

ACCEPTED MANUSCRIPT 23,24

. However, the lack of validation data as well as the large continuous scale of

CROES nomogram makes it difficult and impractical to implement in a busy clinical routine.

RI PT

The imaging modalities in which the scoring systems were developed also demonstrate inconsistencies. Since the preoperative CT is the gold standard imaging modality, it is important that these scoring systems are attainable from a CT scan and

SC

have been validated based on CT images. The Guy’s Score and CROES nomogram were initially developed using abdominal x-ray, while S.T.O.N.E. Nephrolithometry was

M AN U

developed based on CT and consists of variables that are obtained specifically from CT images making it best suited for use with the contemporary imaging modalities. Stone size is an example of a variable easily and most accurately measured on CT imaging that was not taken into account by the Guy’s Score. Other important variables like tract

TE D

length, stone density and severity of hydronephrosis are also measured exclusively on CT and are only incorporated into S.T.O.N.E. Nephrolithometry. When considering the optimal scoring system, it is essential that it must be

EP

reproducible, easily implementable and adequately comprehensive for thorough reporting and comparison. While considering all the limitations, we believe that the

AC C

S.T.O.N.E. Nephrolithometry provides more accurate risk stratification data than the Guy’s Score, yet offers easier application than the CROES nomogram. After careful review of these systems we believe that the S.T.O.N.E. Nephrolithometry is the most comprehensive scoring system while remaining simple to implement in every day practice. It is easily remembered and applied with a simple acronym that has been demonstrated to be reproducible22. Furthermore, S.T.O.N.E. Nephrolithometry is the only scoring system that has been developed strictly from CT imaging, which is routinely

ACCEPTED MANUSCRIPT obtained on almost all patients with urolithiasis. Although the Guy’s Score’s also was very easy to implement, being confined to only four grades provides limited information on the extent of disease25. This hinders its ability to stratify disease complexity thus

RI PT

limiting its utility in academic reporting and patient education26. Although limitations are inherent with retrospective design of this study, we minimized these limitations with standardized data collection methods and strict

SC

outcomes definitions and follow up protocols11,12. Another possible limitation of this study was the exclusion criteria, which included patients with prior ipsilateral

M AN U

surgery and those with a stent or nephrostomy tube placed prior to the procedure. These patients were excluded as these cases are often more complex and do not reflect the typical PCNL experience. In addition, the data included in this study represents the experience of fellowship-trained surgeons from three academic

generalizability of the data.

EP

CONCLUSIONS

TE D

centers. Although surgical techniques may slightly differ, our results support

Guy’s Score, S.T.O.N.E. Nephrolithometry, and CROES nomogram were equally

AC C

predictive of SFS in patients undergoing PCNL. Guy’s Score and S.T.O.N.E. Nephrolithometry were associated with EBL and LOS. Further investigation is needed to determine a single scoring system to be adopted for unified academic reporting and preoperative prediction for the treatment of renal calculi with PCNL.

ACCEPTED MANUSCRIPT REFERENCES:

6. 7. 8. 9.

10. 11.

12. 13. 14.

15.

16. 17.

18.

19.

RI PT

SC

5.

M AN U

4.

TE D

3.

EP

2.

Scales CD, Jr., Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America P. Prevalence of kidney stones in the United States. European urology. Jul 2012;62(1):160-165. Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. The Journal of urology. Jun 2005;173(6):1991-2000. Ghani KR, Sammon JD, Bhojani N, et al. Trends in percutaneous nephrolithotomy use and outcomes in the United States. The Journal of urology. Aug 2013;190(2):558-564. Sivalingam S, Cannon ST, Nakada SY. Current practices in percutaneous nephrolithotomy among endourologists. Journal of endourology / Endourological Society. May 2014;28(5):524-527. Mirheydar HS, Palazzi KL, Derweesh IH, Chang DC, Sur RL. Percutaneous nephrolithotomy use is increasing in the United States: an analysis of trends and complications. Journal of endourology / Endourological Society. Aug 2013;27(8):979-983. Thomas K, Smith NC, Hegarty N, Glass JM. The Guy's stone score--grading the complexity of percutaneous nephrolithotomy procedures. Urology. Aug 2011;78(2):277-281. Okhunov Z, Friedlander JI, George AK, et al. S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi. Urology. Jun 2013;81(6):1154-1159. Smith A, Averch TD, Shahrour K, et al. A nephrolithometric nomogram to predict treatment success of percutaneous nephrolithotomy. The Journal of urology. Jul 2013;190(1):149-156. Hyams ES, Bruhn A, Lipkin M, Shah O. Heterogeneity in the reporting of disease characteristics and treatment outcomes in studies evaluating treatments for nephrolithiasis. Journal of endourology / Endourological Society. Sep 2010;24(9):1411-1414. Opondo D, Gravas S, Joyce A, et al. Standardization of Patient Outcomes Reporting in Percutaneous Nephrolithotomy. Journal of endourology / Endourological Society. Apr 16 2014. Raman JD, Bagrodia A, Bensalah K, Pearle MS, Lotan Y. Residual fragments after percutaneous nephrolithotomy: cost comparison of immediate second look flexible nephroscopy versus expectant management. The Journal of urology. Jan 2010;183(1):188-193. Raman JD, Bagrodia A, Gupta A, et al. Natural history of residual fragments following percutaneous nephrostolithotomy. The Journal of urology. Mar 2009;181(3):1163-1168. de la Rosette JJ, Opondo D, Daels FP, et al. Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. European urology. Aug 2012;62(2):246-255. Andonian S, Okhunov Z, Shapiro EY, Smith AD, Okeke Z. Diagnostic utility and clinical value of postpercutaneous nephrolithotomy nephrostogram. Journal of endourology / Endourological Society. Sep 2010;24(9):1427-1430. Li R, Louie MK, Lee HJ, et al. Prospective randomized trial of three different methods of nephrostomy tract closure after percutaneous nephrolithotripsy. BJU international. May 2011;107(10):1660-1665. Penbegul N, Hatipoglu NK, Bodakci MN, et al. Role of ultrasonography in percutaneous renal access in patients with renal anatomic abnormalities. Urology. May 2013;81(5):938-942. Osther PJ, Razvi H, Liatsikos E, et al. Percutaneous nephrolithotomy among patients with renal anomalies: patient characteristics and outcomes; a subgroup analysis of the clinical research office of the endourological society global percutaneous nephrolithotomy study. Journal of endourology / Endourological Society. Oct 2011;25(10):1627-1632. Mandal S, Goel A, Kathpalia R, et al. Prospective evaluation of complications using the modified Clavien grading system, and of success rates of percutaneous nephrolithotomy using Guy's Stone Score: A single-center experience. Indian J Urol. Oct 2012;28(4):392-398. Ingimarsson JP, Dagrosa LM, Hyams ES, Pais VM, Jr. External validation of a preoperative renal stone grading system: reproducibility and inter-rater concordance of the Guy's stone score using

AC C

1.

ACCEPTED MANUSCRIPT

25.

26.

RI PT

SC

24.

M AN U

23.

TE D

22.

EP

21.

AC C

20.

preoperative computed tomography and rigorous postoperative stone-free criteria. Urology. Jan 2014;83(1):45-49. Okhunov Z, Moreira D, George A, et al. PD32-09 MULTICENTER VALIDATION OF S.T.O.N.E. NEPHROLITHOMETRY. The Journal of urology.191(4):e839. Arash Akhavein CH, Vincent G Bird. PREDICTION OF SINGLE PROCEDURE SUCCESS RATE USING S.T.O.N.E. NEPHROLITHOMETRY SURGICAL CLASSIFICATION SYSTEM WITH STRICT CRITERIA FOR SURGICAL OUTCOME. Journal of Urology. april 2013;189(4):e627-e628. Okhunov Z, Helmy M, Perez-Lansac A, et al. Interobserver Reliability and Reproducibility of S.T.O.N.E. Nephrolithometry for Renal Calculi. Journal of endourology / Endourological Society. Oct 2013;27(10):1303-1306. Kattan MW. Comparison of Cox regression with other methods for determining prediction models and nomograms. The Journal of urology. Dec 2003;170(6 Pt 2):S6-9; discussion S10. Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying highrisk patients: preoperative application in prostate cancer. Current opinion in urology. Mar 2003;13(2):111-116. Vicentini FC, Marchini GS, Mazzucchi E, Claro JF, Srougi M. Utility of the Guy's Stone Score Based on Computed Tomographic Scan Findings for Predicting Percutaneous Nephrolithotomy Outcomes. Urology. Mar 5 2014. Matlaga BR, Hyams ES. Stones: can the Guy's stone score predict PNL outcomes? Nature reviews. Urology. Jul 2011;8(7):363-364.

ACCEPTED MANUSCRIPT Table 1. Patient demographics and clinical characteristics.

N Age (years)

Stone Free

Non-Stone Free

N (%) or Mean (SD)

N (%) or Mean (SD)

137 (56)

107 (44)

-

55.7 (14.9)

55.1 (15.0)

0.774

68 (63)

40 (37)

69 (51)

67 (49)

Gender

-

Male Female

1 2 3 4

13 (68)

Laterality

Left Right

BMI (Kg/m2) Punctures Operative time (min)

LOS (days) Stone Size (mm2)

AC C

Calyces (n)

EP

EBL (mL)

Staghorn Stones (%) Essence (HU)

0.056

0.432

42 (48)

60 (59)

42 (41)

4 (80)

1 (20)

77 (58)

55 (42)

60 (54)

52 (46)

30.6 (8.6)

30.2 (7.7)

0.711

1.0 (0.1)

1.2 (0.6)

0.009

122 (53)

152 (65)

<0.001

68 (71)

101 (113)

0.005

3.1 (2.7)

3.2 (2.7)

0.608

654 (617)

1525 (1869)

<0.001

1.86 (1-4)

2.5 (1-5)

0.001

19

36

0.001

937 (305-1580)

937 (389-1849)

0.435

41 (53)

36 (47)

0.135

24 (59)

17 (41)

68 (61)

44 (39)

4 (29)

10 (71)

TE D

-

6 (32)

M AN U

46 (52)

SC

ASA Score

-

p-value

RI PT

Variable

0.455

Location (%)

-

Upper pole Mid pole Lower pole Multiple Locations

ACCEPTED MANUSCRIPT Table 2: Stone free rate for all three scoring systems. Scoring systems

Stone Free Rate

Guy’s Score Grade 1

33/47 (70.2%)

-

Grade 2

53/81 (65.4%)

-

Grade 3

37/77 (48.1%)

-

Grade 4

14/39 (35.9%)

SC

RI PT

-

S.T.O.N.E. Score categories

5-6

-

7-8

-

9-13

24/34 (70.6%)

M AN U

-

-

130-169

-

170-219

-

>=220

EP

80-129

AC C

-

TE D

CROES Nomogram

53/80 (66.3%) 70/130 (46.2%)

5/22 (22.7%) 26/56 (46.4%) 25/55 (45.5%) 80/110 (72.7%)

ACCEPTED MANUSCRIPT Table 3: ROC curve values for Guy’s Score, S.T.O.N.E. Score, CROES nomogram and stone burden. Asymptotic Interval

Scoring System

ROC Curve (95% Confidence Interval) 0.634

0.566-0.702

S.T.O.N.E. Score

0.670

0.602-0.738

CROES Nomogram

0.671

0.602-0.739

Stone Burden

0.668

0.599-0.737

AC C

EP

TE D

M AN U

SC

RI PT

Guy’s Score

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

Figure 1: ROC curve for STONE score, Guy’s score, CROES nomogram and stone size.